| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 7.27e-08 | 16 | 52 | 4 | GO:0023029 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 1.54e-07 | 19 | 52 | 4 | GO:0032394 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 4.68e-06 | 43 | 52 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 6.65e-06 | 2 | 52 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 1.10e-05 | 17 | 52 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.46e-05 | 57 | 52 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.56e-05 | 58 | 52 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.79e-05 | 60 | 52 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.46e-05 | 65 | 52 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.46e-05 | 65 | 52 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 2.84e-05 | 23 | 52 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 3.14e-05 | 140 | 52 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51A4 TGFBR3 MET IL12RB2 HTR3E KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 CHRNA2 CHRNA4 CHRNB1 OR51H1 | 3.15e-05 | 1353 | 52 | 13 | GO:0004888 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.33e-05 | 75 | 52 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.81e-05 | 77 | 52 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | immune receptor activity | 6.88e-05 | 165 | 52 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.33e-04 | 100 | 52 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.44e-04 | 193 | 52 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.58e-04 | 197 | 52 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.23e-04 | 334 | 52 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 5.09e-04 | 13 | 52 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.19e-03 | 459 | 52 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.95e-03 | 343 | 52 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | channel activity | 2.34e-03 | 525 | 52 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.37e-03 | 526 | 52 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 5.97e-03 | 279 | 52 | 4 | GO:0005096 | |
| GeneOntologyMolecularFunction | quaternary ammonium group binding | 6.40e-03 | 46 | 52 | 2 | GO:0050997 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.01e-06 | 130 | 53 | 6 | GO:0060079 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 2.06e-06 | 147 | 53 | 6 | GO:0099565 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 6.64e-06 | 180 | 53 | 6 | GO:0060078 | |
| GeneOntologyBiologicalProcess | response to nicotine | 1.49e-05 | 58 | 53 | 4 | GO:0035094 | |
| GeneOntologyBiologicalProcess | S-adenosylmethionine biosynthetic process | 3.87e-05 | 4 | 53 | 2 | GO:0006556 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in morphogenesis | 1.35e-04 | 7 | 53 | 2 | GO:1902338 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 1.77e-04 | 109 | 53 | 4 | GO:0090630 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in development | 1.80e-04 | 8 | 53 | 2 | GO:1904746 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 1.97e-04 | 44 | 53 | 3 | GO:0007271 | |
| GeneOntologyBiologicalProcess | amino acid metabolic process | 2.02e-04 | 332 | 53 | 6 | GO:0006520 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 2.12e-04 | 335 | 53 | 6 | GO:0043087 | |
| GeneOntologyBiologicalProcess | aspartate family amino acid metabolic process | 2.55e-04 | 48 | 53 | 3 | GO:0009066 | |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 3.06e-04 | 51 | 53 | 3 | GO:0095500 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 3.43e-04 | 53 | 53 | 3 | GO:1905145 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 3.51e-04 | 11 | 53 | 2 | GO:0035095 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 4.02e-04 | 244 | 53 | 5 | GO:0043547 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 4.03e-04 | 56 | 53 | 3 | GO:1905144 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process | 4.96e-04 | 13 | 53 | 2 | GO:2001054 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 5.41e-04 | 559 | 53 | 7 | GO:0042391 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 5.97e-04 | 150 | 53 | 4 | GO:0050773 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in morphogenesis | 6.66e-04 | 15 | 53 | 2 | GO:1902337 | |
| GeneOntologyBiologicalProcess | aspartate family amino acid catabolic process | 6.66e-04 | 15 | 53 | 2 | GO:0009068 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 1.22e-05 | 18 | 53 | 3 | GO:0005892 | |
| GeneOntologyCellularComponent | methionine adenosyltransferase complex | 1.89e-05 | 3 | 53 | 2 | GO:0048269 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 5.42e-04 | 405 | 53 | 6 | GO:0045211 | |
| GeneOntologyCellularComponent | receptor complex | 6.29e-04 | 581 | 53 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.41e-04 | 583 | 53 | 7 | GO:0097060 | |
| MousePheno | fused cornea and lens | 4.89e-05 | 24 | 42 | 3 | MP:0001307 | |
| MousePheno | abnormal lens development | 8.55e-05 | 78 | 42 | 4 | MP:0005545 | |
| Domain | - | 4.55e-07 | 23 | 52 | 4 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 4.55e-07 | 23 | 52 | 4 | IPR027361 | |
| Domain | Neurotransmitter_ion_chnl_CS | 7.31e-06 | 45 | 52 | 4 | IPR018000 | |
| Domain | S-AdoMet_synt_M | 7.60e-06 | 2 | 52 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 7.60e-06 | 2 | 52 | 2 | PF02773 | |
| Domain | ADOMET_SYNTHASE_CS | 7.60e-06 | 2 | 52 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 7.60e-06 | 2 | 52 | 2 | IPR022630 | |
| Domain | S-AdoMet_synthetase_sfam | 7.60e-06 | 2 | 52 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_N | 7.60e-06 | 2 | 52 | 2 | PF00438 | |
| Domain | S-AdoMet_synt_central | 7.60e-06 | 2 | 52 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 7.60e-06 | 2 | 52 | 2 | IPR022628 | |
| Domain | S-AdoMet_synthetase | 7.60e-06 | 2 | 52 | 2 | IPR002133 | |
| Domain | ADOMET_SYNTHASE_1 | 7.60e-06 | 2 | 52 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 7.60e-06 | 2 | 52 | 2 | PS00377 | |
| Domain | Neur_chan_memb | 7.99e-06 | 46 | 52 | 4 | PF02932 | |
| Domain | Neur_chan_LBD | 8.72e-06 | 47 | 52 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 8.72e-06 | 47 | 52 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 8.72e-06 | 47 | 52 | 4 | IPR006029 | |
| Domain | - | 8.72e-06 | 47 | 52 | 4 | 2.70.170.10 | |
| Domain | Neur_channel | 8.72e-06 | 47 | 52 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 8.72e-06 | 47 | 52 | 4 | IPR006202 | |
| Domain | Nicotinic_acetylcholine_rcpt | 1.11e-05 | 16 | 52 | 3 | IPR002394 | |
| Domain | ArfGap | 7.07e-05 | 29 | 52 | 3 | SM00105 | |
| Domain | ArfGap | 7.07e-05 | 29 | 52 | 3 | PF01412 | |
| Domain | ARFGAP | 7.07e-05 | 29 | 52 | 3 | PS50115 | |
| Domain | ArfGAP | 7.07e-05 | 29 | 52 | 3 | IPR001164 | |
| Domain | ig | 1.82e-04 | 190 | 52 | 5 | PF00047 | |
| Domain | Immunoglobulin | 1.82e-04 | 190 | 52 | 5 | IPR013151 | |
| Domain | Ig-like_fold | 3.26e-03 | 706 | 52 | 7 | IPR013783 | |
| Domain | Ntn_hydrolases_N | 3.80e-03 | 33 | 52 | 2 | IPR029055 | |
| Domain | LAM_G_DOMAIN | 5.01e-03 | 38 | 52 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 5.54e-03 | 40 | 52 | 2 | PF02210 | |
| Domain | IG | 6.19e-03 | 421 | 52 | 5 | SM00409 | |
| Domain | Ig_sub | 6.19e-03 | 421 | 52 | 5 | IPR003599 | |
| Domain | LamG | 6.67e-03 | 44 | 52 | 2 | SM00282 | |
| Domain | PH | 7.43e-03 | 278 | 52 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 7.52e-03 | 279 | 52 | 4 | PS50003 | |
| Domain | PH_domain | 7.61e-03 | 280 | 52 | 4 | IPR001849 | |
| Domain | - | 9.95e-03 | 663 | 52 | 6 | 2.60.40.10 | |
| Domain | Laminin_G | 1.14e-02 | 58 | 52 | 2 | IPR001791 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 7.58e-06 | 88 | 44 | 5 | M16004 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 7.68e-06 | 41 | 44 | 4 | M13519 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.33e-05 | 54 | 44 | 4 | MM14871 | |
| Pathway | KEGG_SELENOAMINO_ACID_METABOLISM | 7.02e-05 | 26 | 44 | 3 | M7151 | |
| Pathway | WP_METHYLATION_PATHWAYS | 3.38e-04 | 9 | 44 | 2 | M39493 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.38e-04 | 9 | 44 | 2 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.38e-04 | 9 | 44 | 2 | MM15313 | |
| Pathway | WP_METHYLATION | 3.38e-04 | 9 | 44 | 2 | MM15836 | |
| Pathway | KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION | 4.22e-04 | 10 | 44 | 2 | M47939 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 5.14e-04 | 11 | 44 | 2 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 6.16e-04 | 12 | 44 | 2 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 6.16e-04 | 12 | 44 | 2 | MM15312 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 8.11e-04 | 135 | 44 | 4 | MM14781 | |
| Pathway | REACTOME_METHYLATION | 8.46e-04 | 14 | 44 | 2 | MM14596 | |
| Pathway | REACTOME_METHYLATION | 8.46e-04 | 14 | 44 | 2 | M26967 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 8.46e-04 | 14 | 44 | 2 | M757 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 8.57e-04 | 137 | 44 | 4 | M5669 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 9.74e-04 | 15 | 44 | 2 | MM14704 | |
| Pubmed | 3.78e-13 | 8 | 53 | 5 | 15730517 | ||
| Pubmed | 4.80e-12 | 4 | 53 | 4 | 18269867 | ||
| Pubmed | 1.34e-11 | 14 | 53 | 5 | 19875891 | ||
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 1.34e-11 | 14 | 53 | 5 | 15896204 | |
| Pubmed | 1.34e-11 | 14 | 53 | 5 | 19489269 | ||
| Pubmed | 2.01e-11 | 15 | 53 | 5 | 20082646 | ||
| Pubmed | 2.01e-11 | 15 | 53 | 5 | 19926642 | ||
| Pubmed | 2.01e-11 | 15 | 53 | 5 | 20356536 | ||
| Pubmed | 2.01e-11 | 15 | 53 | 5 | 20643584 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 2.01e-11 | 15 | 53 | 5 | 17498266 | |
| Pubmed | 2.01e-11 | 15 | 53 | 5 | 19326408 | ||
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 19897003 | ||
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 19000141 | ||
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 20670355 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 2.92e-11 | 16 | 53 | 5 | 19527230 | |
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 20652381 | ||
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 18668235 | ||
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 19279038 | ||
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 17868255 | ||
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 18643961 | ||
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 19309280 | ||
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 20331834 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 2.92e-11 | 16 | 53 | 5 | 16403292 | |
| Pubmed | 2.92e-11 | 16 | 53 | 5 | 20210919 | ||
| Pubmed | 4.13e-11 | 17 | 53 | 5 | 19032228 | ||
| Pubmed | 4.13e-11 | 17 | 53 | 5 | 20173792 | ||
| Pubmed | 4.13e-11 | 17 | 53 | 5 | 20483367 | ||
| Pubmed | 4.13e-11 | 17 | 53 | 5 | 19968064 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 4.13e-11 | 17 | 53 | 5 | 19218127 | |
| Pubmed | 4.13e-11 | 17 | 53 | 5 | 19169284 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 4.13e-11 | 17 | 53 | 5 | 20878400 | |
| Pubmed | 4.13e-11 | 17 | 53 | 5 | 20650299 | ||
| Pubmed | 4.13e-11 | 17 | 53 | 5 | 19450876 | ||
| Pubmed | 4.13e-11 | 17 | 53 | 5 | 19761533 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 5.71e-11 | 18 | 53 | 5 | 19630074 | |
| Pubmed | 5.71e-11 | 18 | 53 | 5 | 20519398 | ||
| Pubmed | 5.71e-11 | 18 | 53 | 5 | 20200544 | ||
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 5.71e-11 | 18 | 53 | 5 | 19046302 | |
| Pubmed | 5.71e-11 | 18 | 53 | 5 | 19846535 | ||
| Pubmed | 5.71e-11 | 18 | 53 | 5 | 20580654 | ||
| Pubmed | 5.71e-11 | 18 | 53 | 5 | 20210918 | ||
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 7.75e-11 | 19 | 53 | 5 | 18571006 | |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 7.75e-11 | 19 | 53 | 5 | 18778326 | |
| Pubmed | 7.75e-11 | 19 | 53 | 5 | 20600442 | ||
| Pubmed | 7.75e-11 | 19 | 53 | 5 | 18848853 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 1.03e-10 | 20 | 53 | 5 | 20193031 | |
| Pubmed | 1.35e-10 | 21 | 53 | 5 | 19861144 | ||
| Pubmed | 1.68e-10 | 7 | 53 | 4 | 12618911 | ||
| Pubmed | Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. | 1.68e-10 | 7 | 53 | 4 | 15748957 | |
| Pubmed | 1.75e-10 | 22 | 53 | 5 | 20492596 | ||
| Pubmed | 3.35e-10 | 8 | 53 | 4 | 20935224 | ||
| Pubmed | 6.02e-10 | 9 | 53 | 4 | 7749980 | ||
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 7.82e-10 | 29 | 53 | 5 | 20082482 | |
| Pubmed | 1.00e-09 | 10 | 53 | 4 | 12559621 | ||
| Pubmed | 1.57e-09 | 11 | 53 | 4 | 18830515 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 1.57e-09 | 11 | 53 | 4 | 19664392 | |
| Pubmed | 2.12e-09 | 35 | 53 | 5 | 19683555 | ||
| Pubmed | 2.36e-09 | 12 | 53 | 4 | 20371502 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 2.36e-09 | 12 | 53 | 4 | 19181658 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 2.36e-09 | 12 | 53 | 4 | 17490516 | |
| Pubmed | 2.36e-09 | 12 | 53 | 4 | 19936734 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 30698860 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 15879158 | ||
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 19549382 | ||
| Pubmed | 3.40e-09 | 13 | 53 | 4 | 18687225 | ||
| Pubmed | 3.40e-09 | 13 | 53 | 4 | 19934297 | ||
| Pubmed | 3.40e-09 | 13 | 53 | 4 | 19120281 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 4.76e-09 | 14 | 53 | 4 | 19421224 | |
| Pubmed | 4.76e-09 | 14 | 53 | 4 | 18945962 | ||
| Pubmed | 6.48e-09 | 15 | 53 | 4 | 19850842 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 6.48e-09 | 15 | 53 | 4 | 20207982 | |
| Pubmed | 6.48e-09 | 15 | 53 | 4 | 19493232 | ||
| Pubmed | 1.13e-08 | 17 | 53 | 4 | 20173784 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 20056126 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 16571411 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 18632158 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 19522772 | ||
| Pubmed | [Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations]. | 1.34e-08 | 4 | 53 | 3 | 18543232 | |
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 27732638 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 25037176 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 26542066 | ||
| Pubmed | 1.34e-08 | 4 | 53 | 3 | 23354323 | ||
| Pubmed | 2.29e-08 | 20 | 53 | 4 | 20426625 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 16112031 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 7716543 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 12121272 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 18755860 | ||
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 18322206 | ||
| Pubmed | KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer. | 3.33e-08 | 5 | 53 | 3 | 27893413 | |
| Pubmed | 1.16e-07 | 7 | 53 | 3 | 14607943 | ||
| Pubmed | 1.16e-07 | 7 | 53 | 3 | 26928464 | ||
| Pubmed | Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. | 1.16e-07 | 7 | 53 | 3 | 11169255 | |
| Pubmed | 1.16e-07 | 7 | 53 | 3 | 9430220 | ||
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 1.86e-07 | 8 | 53 | 3 | 17200871 | |
| Pubmed | 1.86e-07 | 8 | 53 | 3 | 9430221 | ||
| Pubmed | 1.86e-07 | 8 | 53 | 3 | 18681957 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 2.79e-07 | 9 | 53 | 3 | 12640130 | |
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 2.79e-07 | 9 | 53 | 3 | 8662091 | |
| Pubmed | 2.79e-07 | 9 | 53 | 3 | 18186800 | ||
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 3.98e-07 | 10 | 53 | 3 | 20664521 | |
| Interaction | KIR3DL1 interactions | 4.55e-06 | 13 | 52 | 3 | int:KIR3DL1 | |
| Interaction | KIR2DL2 interactions | 4.55e-06 | 13 | 52 | 3 | int:KIR2DL2 | |
| Interaction | KIR2DL1 interactions | 5.07e-05 | 28 | 52 | 3 | int:KIR2DL1 | |
| Cytoband | 19q13.4 | 2.23e-06 | 79 | 53 | 4 | 19q13.4 | |
| Cytoband | 10q11.23 | 6.75e-04 | 33 | 53 | 2 | 10q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 1.36e-03 | 188 | 53 | 3 | chr10q11 | |
| Cytoband | 22q11.23 | 1.74e-03 | 53 | 53 | 2 | 22q11.23 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 5.65e-10 | 18 | 44 | 5 | 620 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 7.37e-06 | 16 | 44 | 3 | 173 | |
| GeneFamily | ArfGAPs | 6.97e-05 | 33 | 44 | 3 | 395 | |
| GeneFamily | Cadherin related | 7.69e-04 | 17 | 44 | 2 | 24 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 7.69e-04 | 17 | 44 | 2 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.56e-03 | 206 | 44 | 4 | 682 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.59e-03 | 394 | 44 | 5 | 471 | |
| GeneFamily | Olfactory receptors, family 51 | 5.13e-03 | 44 | 44 | 2 | 164 | |
| Coexpression | KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE | 6.68e-10 | 49 | 53 | 6 | M40909 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 9.36e-07 | 37 | 53 | 4 | MM1121 | |
| Coexpression | HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE | 1.29e-06 | 40 | 53 | 4 | M41034 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL | 6.23e-06 | 18 | 53 | 3 | M45763 | |
| Coexpression | GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN | 4.11e-05 | 190 | 53 | 5 | M4662 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN | 5.12e-05 | 199 | 53 | 5 | M9885 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 6.46e-05 | 209 | 53 | 5 | MM1058 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 9.75e-05 | 44 | 53 | 3 | MM485 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 2.70e-09 | 189 | 53 | 7 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 3.36e-09 | 195 | 53 | 7 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.46e-08 | 171 | 53 | 6 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue | 5.66e-08 | 172 | 53 | 6 | 701de463f85aaad3a4b36a0d5fbc416406620089 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-NK-Activated_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.48e-08 | 176 | 53 | 6 | 6802ed40eb0f91674d4f0120a3d4888c8a2e9612 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.71e-08 | 177 | 53 | 6 | 0f2616a81f8fbede77c860b2126e3fa826672da3 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-08 | 180 | 53 | 6 | 1c8398342d3fa4d5ca9a8a63626cc497c5291446 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-08 | 180 | 53 | 6 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-08 | 180 | 53 | 6 | 0a98d21fec67a890e75ebf0e2d23adddd77da214 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.99e-08 | 186 | 53 | 6 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 9.89e-08 | 189 | 53 | 6 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-07 | 192 | 53 | 6 | e48bbcb97c113f323ad4db96bd10d593b9206923 | |
| ToppCell | Immune-natural_killer_cell|World / Lineage, Cell type, age group and donor | 1.09e-07 | 192 | 53 | 6 | 68121a6ef4115a93d87aad8802ef9b27d793d8c0 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 1.15e-07 | 194 | 53 | 6 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 1.15e-07 | 194 | 53 | 6 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.15e-07 | 194 | 53 | 6 | ae5357e2a276473cde1fc8c43acaf9f69da35fd7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.15e-07 | 194 | 53 | 6 | 3a0b8b5d0354c43da57bb951cd8ba878363c3de5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 1.19e-07 | 195 | 53 | 6 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | Influenza_Severe-NK|Influenza_Severe / Disease group and Cell class | 1.26e-07 | 197 | 53 | 6 | d0f58ee4c02573d214deb210bb7efd3d6118f267 | |
| ToppCell | Severe_COVID-19-T/NK-NK|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.26e-07 | 197 | 53 | 6 | cc20162892b59e48653981f91fc9a0c27064444d | |
| ToppCell | Severe-Lymphoid-NK-NK|Severe / Condition, Lineage, Cell class and cell subclass | 1.26e-07 | 197 | 53 | 6 | d5b94f9f73e9d050245841b19b046242a32c6258 | |
| ToppCell | Severe-Lymphoid-NK|Severe / Condition, Lineage, Cell class and cell subclass | 1.30e-07 | 198 | 53 | 6 | 26b6d20527d22ce68067cdaea6b4330cb779f91b | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.34e-07 | 199 | 53 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.34e-07 | 199 | 53 | 6 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | COVID-19_Moderate-NK|World / disease group, cell group and cell class | 1.34e-07 | 199 | 53 | 6 | c41b67b760831c7d5e19fabcc932a056dc560f93 | |
| ToppCell | COVID-19_Moderate-NK|COVID-19_Moderate / disease group, cell group and cell class | 1.34e-07 | 199 | 53 | 6 | e0e83ba511957be9ad3413460dcb6b7d7b65dd18 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.34e-07 | 199 | 53 | 6 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-07 | 199 | 53 | 6 | 00ef3cc5c02639bfb839075ecf5f20026ff81f84 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.34e-07 | 199 | 53 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-NK|Influenza_Severe / Disease, condition lineage and cell class | 1.38e-07 | 200 | 53 | 6 | 04ac14414d550b14dc46d682e7af9dd43982211a | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-07 | 200 | 53 | 6 | 0a6fc7eff94e2f71af9f31a01779aafd2f4a6699 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.36e-07 | 133 | 53 | 5 | 2ec3490cbf60152c3cece95eb566d749c9666517 | |
| ToppCell | 368C-Lymphocytic-NK_cells|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.72e-07 | 150 | 53 | 5 | 17b3ac5ddc47b9cba0a27b268d63a6e491b2b111 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|GI_small-bowel / Manually curated celltypes from each tissue | 1.14e-06 | 155 | 53 | 5 | 1c67f58ed79331addbc012dab0cb09a7f350aedb | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-06 | 181 | 53 | 5 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.58e-06 | 183 | 53 | 5 | 8746e6ecc6bf9e194cc9cdf9b07da63f0fcf8b5f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-06 | 183 | 53 | 5 | bbf27d2f4369031fadacacd6c432c06b1ec5abdb | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 2.72e-06 | 185 | 53 | 5 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.80e-06 | 186 | 53 | 5 | facc1bd8920003ad03d1893c32fc606d82b4d50a | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 2.87e-06 | 187 | 53 | 5 | 4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-06 | 188 | 53 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 2.95e-06 | 188 | 53 | 5 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.95e-06 | 188 | 53 | 5 | 0a2be6eac6fde669fbc58fd1b2e93e4acf17ddde | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.02e-06 | 189 | 53 | 5 | 723c57f278919e8251d56b3d19411f9088319450 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.02e-06 | 189 | 53 | 5 | 960374f5fb278659500a7c948c3068a95dd62eb0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.10e-06 | 190 | 53 | 5 | b9182c84e44aa31684b5388cf3ef4fd1b9e51de4 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.10e-06 | 190 | 53 | 5 | 1f890be1ac8613a098b271945f25a58c3c2530ab | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-06 | 190 | 53 | 5 | 88c092a5e78ccaddf406f8fff74376bb761b9790 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-NK|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.10e-06 | 190 | 53 | 5 | 86b0d142b7d1a3b35580edd104f947106be2c9c6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.10e-06 | 190 | 53 | 5 | 4b42a16902d7d1494f953cc88af1e761e76bdf2c | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.10e-06 | 190 | 53 | 5 | d7cecf88451f736f8f3f6f4644504cf22846cd6e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-06 | 190 | 53 | 5 | 9501f0995f3d52be90c02b1aa0c7d184bd788c16 | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 3.10e-06 | 190 | 53 | 5 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 3.18e-06 | 191 | 53 | 5 | f802a4686ecf00e8302047bfe23356f24b266cf8 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-06 | 191 | 53 | 5 | 9b8b64a36e27a2523b8730c7922fd7ad865a021e | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.26e-06 | 192 | 53 | 5 | 63e815664b228575886396387d2738cd73855759 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 3.26e-06 | 192 | 53 | 5 | 4d72b9264ed62e0c08cde4078061b348253f6989 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.26e-06 | 192 | 53 | 5 | 095151a4f878944835945f698aa0e3b540ffc8c3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 3.35e-06 | 193 | 53 | 5 | e325cf49e159c6be205ed93adaa09efdd0c122b4 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 3.35e-06 | 193 | 53 | 5 | a98ee519e0da93ae4a2dcdda1ee8b4138dec131b | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|World / disease group, cell group and cell class | 3.35e-06 | 193 | 53 | 5 | ddc1db516568e03be8e82b2ca770c67756418185 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.35e-06 | 193 | 53 | 5 | 46f94a1062b098205e8ce3ed380c0202a4d97678 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.35e-06 | 193 | 53 | 5 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.43e-06 | 194 | 53 | 5 | 5a859885c0f9b8554b0d203e371c70928ad4418f | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.43e-06 | 194 | 53 | 5 | 7d35ac70ba966eb1fee4197f7de6d6116326a442 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK|ICU-NoSEP / Disease, Lineage and Cell Type | 3.43e-06 | 194 | 53 | 5 | 090edfc884655e5ab38b027c6e1a5aa809ebb19d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.43e-06 | 194 | 53 | 5 | 5afe7f48d3383f3dac18765f97999c8b6936dc1b | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.43e-06 | 194 | 53 | 5 | ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5 | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.43e-06 | 194 | 53 | 5 | 335c6c2f3f319d4f19eace62f8826a0f40c130f6 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 3.43e-06 | 194 | 53 | 5 | 3337042eef91a49f621058785723228cf4dfdad4 | |
| ToppCell | IIF-Lymphocyte-T_NK-NK|IIF / Disease, Lineage and Cell Type | 3.52e-06 | 195 | 53 | 5 | 464ce05cb52f78aee22d3baa6641b37bd53aae16 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-06 | 195 | 53 | 5 | 98b02beafe1d418442e41f85cbf0c7b194fe5957 | |
| ToppCell | COVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type | 3.52e-06 | 195 | 53 | 5 | 3ab941a369e3815f338890b116dc77aefa054098 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 3.52e-06 | 195 | 53 | 5 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 3.52e-06 | 195 | 53 | 5 | e756733cf48768bf40058d6cf9039e52f7563133 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-06 | 195 | 53 | 5 | 9ecae6c26a0d0607d101ccf1c38f0b23c5a256a8 | |
| ToppCell | COVID-19-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 3.52e-06 | 195 | 53 | 5 | d4c70a462b98963e78f4e2659574bc350f8ffe1a | |
| ToppCell | T/NK_cells-CD56dim_NK_cell|World / Lineage and Cell class | 3.52e-06 | 195 | 53 | 5 | 6124e87cb9061bf8918377fb4a79084079ddfc16 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-06 | 195 | 53 | 5 | 0b50b5c71a4949f3f8fb9f5c30f9d50f53ca050d | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue | 3.61e-06 | 196 | 53 | 5 | e6d4853ccefbcd45a019cee595811f0474dcc036 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.61e-06 | 196 | 53 | 5 | 78b28b263deaa43590b38597186222c6447ad25f | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-Intermediate_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.61e-06 | 196 | 53 | 5 | a2f938022a080202bce5bb157d13b86b69054468 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 3.61e-06 | 196 | 53 | 5 | 93ff94fc2b2ca8bd6a6492cbc0b402daf5d63ea2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.61e-06 | 196 | 53 | 5 | 77da6b1bcab45d376eb0368f540e0ed24ce98b42 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK|COVID-19_Severe / Disease group, lineage and cell class | 3.61e-06 | 196 | 53 | 5 | cc1daf12de5765ba4f7002396352404b41df2012 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 3.61e-06 | 196 | 53 | 5 | f7e5a7fad4547e8ab9ab8b140239281832fb4260 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.61e-06 | 196 | 53 | 5 | f424c45be7f34cbef76e1696dea10c1e3a9af2e0 | |
| ToppCell | BL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.61e-06 | 196 | 53 | 5 | cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.61e-06 | 196 | 53 | 5 | 3e78e307c9c991c1aadc85c61d401431cf75eaec | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.61e-06 | 196 | 53 | 5 | f0566f2ef96584ed6d9247b149218376fb509915 | |
| ToppCell | Control-Lymphocyte-T_NK-NK|Control / Disease, Lineage and Cell Type | 3.61e-06 | 196 | 53 | 5 | 65838fddc920cdcecefe823f3ce1c95a7e50e82b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.61e-06 | 196 | 53 | 5 | d3bd8fab010e76024d7e06aba0ea5df3394f411f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.61e-06 | 196 | 53 | 5 | 9b3848dd4256cd6d9a21ef6bfdbd0cb7c0030005 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 3.61e-06 | 196 | 53 | 5 | a3b077e82b1550eb328c84b567b60179001f9a77 | |
| ToppCell | COVID-19_Severe-NK|World / disease group, cell group and cell class | 3.61e-06 | 196 | 53 | 5 | f46ca7cc2d8407d0dcaa77c4b16a2c1f2a23734d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 3.61e-06 | 196 | 53 | 5 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.70e-06 | 197 | 53 | 5 | 48311c7d85ffabf59fd1685c31c18b3e84a145b5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.70e-06 | 197 | 53 | 5 | 9993fdea353abeafc009ac87439ad25cedf8f1f6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.70e-06 | 197 | 53 | 5 | 300849a922722adcbc068593fc5cc0bef936d9cb | |
| ToppCell | Influenza_Severe-NK|World / Disease group and Cell class | 3.70e-06 | 197 | 53 | 5 | 565d578f7a28a19175d56663bf30c60e0d5e1b22 | |
| Computational | Porins / transporters. | 1.76e-07 | 211 | 33 | 8 | MODULE_63 | |
| Computational | Ion channels. | 2.09e-06 | 70 | 33 | 5 | MODULE_316 | |
| Computational | AcetylCholine receptors. | 9.38e-06 | 14 | 33 | 3 | MODULE_328 | |
| Computational | Genes in the cancer module 267. | 1.17e-05 | 15 | 33 | 3 | MODULE_267 | |
| Computational | Ion channels. | 7.33e-05 | 27 | 33 | 3 | MODULE_214 | |
| Computational | Neighborhood of IL2RB | 3.66e-04 | 46 | 33 | 3 | GNF2_IL2RB | |
| Computational | Genes in the cancer module 27. | 6.47e-04 | 355 | 33 | 6 | MODULE_27 | |
| Computational | Genes in the cancer module 138. | 2.34e-03 | 87 | 33 | 3 | MODULE_138 | |
| Drug | Aa1 | 3.48e-08 | 83 | 52 | 6 | CID009549188 | |
| Drug | glycoluril | 1.35e-07 | 53 | 52 | 5 | CID000062347 | |
| Drug | D-Au | 8.90e-07 | 77 | 52 | 5 | CID000277822 | |
| Drug | EPTC | 1.20e-06 | 35 | 52 | 4 | CID000012968 | |
| Drug | Dns-C6-Cho | 1.83e-06 | 11 | 52 | 3 | CID000124728 | |
| Drug | AC1L9NC9 | 1.83e-06 | 11 | 52 | 3 | CID000449642 | |
| Drug | dihydronereistoxin | 1.83e-06 | 11 | 52 | 3 | CID000121232 | |
| Drug | bipinnatin-B | 1.83e-06 | 11 | 52 | 3 | CID000127363 | |
| Drug | LJP 1082 | 1.83e-06 | 11 | 52 | 3 | CID003037609 | |
| Drug | 2-methylmethionine | 2.44e-06 | 12 | 52 | 3 | CID000002111 | |
| Drug | AC1L9P8C | 2.44e-06 | 12 | 52 | 3 | CID000450864 | |
| Drug | SureCN373116 | 2.44e-06 | 12 | 52 | 3 | CID010085732 | |
| Drug | nereistoxin | 3.16e-06 | 13 | 52 | 3 | CID000015401 | |
| Drug | 1-acetyl-4-methylpiperazine methiodide | 3.16e-06 | 13 | 52 | 3 | CID004392675 | |
| Drug | C-toxiferine-I | 3.16e-06 | 13 | 52 | 3 | CID005089093 | |
| Drug | bipinnatin-C | 3.16e-06 | 13 | 52 | 3 | CID000129977 | |
| Drug | bipinnatin-A | 3.16e-06 | 13 | 52 | 3 | CID000196603 | |
| Drug | 2,3-dichlorooctafluorobutane | 4.02e-06 | 14 | 52 | 3 | CID000078982 | |
| Drug | LNF 209 | 4.02e-06 | 14 | 52 | 3 | CID000132666 | |
| Drug | oxotremorine | 4.76e-06 | 108 | 52 | 5 | CID000004630 | |
| Drug | aa373 | 5.01e-06 | 15 | 52 | 3 | CID000191672 | |
| Drug | anatoxin-a hydrochloride | 5.01e-06 | 15 | 52 | 3 | CID000135265 | |
| Drug | (-)-pictamine | 5.01e-06 | 15 | 52 | 3 | CID006918623 | |
| Drug | (-)-lepadin B | 5.01e-06 | 15 | 52 | 3 | CID006918624 | |
| Drug | SAD-128 | 5.01e-06 | 15 | 52 | 3 | CID000162008 | |
| Drug | UB-165 | 5.01e-06 | 15 | 52 | 3 | CID004694339 | |
| Drug | N-methylcytisine | 5.01e-06 | 15 | 52 | 3 | CID000234566 | |
| Drug | 2-amino-4-methylthio-3-butenoic acid | 5.12e-06 | 2 | 52 | 2 | ctd:C083253 | |
| Drug | Nabumetone [42924-53-8]; Up 200; 17.6uM; HL60; HT_HG-U133A | 5.52e-06 | 196 | 52 | 6 | 3108_UP | |
| Drug | 3-(trifluoromethyl)-3-(m-iodophenyl)diazirine | 6.16e-06 | 16 | 52 | 3 | CID000123866 | |
| Drug | AC1L2SVN | 6.16e-06 | 16 | 52 | 3 | CID000127922 | |
| Drug | benzoquinonium | 6.16e-06 | 16 | 52 | 3 | CID000009393 | |
| Drug | PNU-282,987 | 6.16e-06 | 16 | 52 | 3 | CID004655349 | |
| Drug | Nsc36388 | 7.47e-06 | 17 | 52 | 3 | CID000014954 | |
| Drug | AC1O8PVM | 8.95e-06 | 18 | 52 | 3 | CID000004989 | |
| Drug | benzetimide | 8.95e-06 | 18 | 52 | 3 | CID000021846 | |
| Drug | ABT-594 | 8.95e-06 | 18 | 52 | 3 | CID003075702 | |
| Drug | AC1LCVGE | 8.95e-06 | 18 | 52 | 3 | CID000656712 | |
| Drug | AC1L9P88 | 1.06e-05 | 19 | 52 | 3 | CID000450860 | |
| Drug | isoarecolone | 1.06e-05 | 19 | 52 | 3 | CID000146970 | |
| Drug | beta-erythroidine | 1.06e-05 | 19 | 52 | 3 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 1.06e-05 | 19 | 52 | 3 | CID000107881 | |
| Drug | PNU-120596 | 1.06e-05 | 19 | 52 | 3 | CID000311434 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 1.06e-05 | 19 | 52 | 3 | CID000162425 | |
| Drug | AC1Q5X7V | 1.25e-05 | 20 | 52 | 3 | CID000050190 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 1.25e-05 | 20 | 52 | 3 | CID000001962 | |
| Drug | Dichloride, Alcuronium | 1.25e-05 | 20 | 52 | 3 | CID003032788 | |
| Drug | potassium | COL4A5 CLCN6 MAT2A SYNE1 KCNK1 AADAT CHRNA2 CHRNA4 SLC2A2 CHRNB1 GGT5 | 1.38e-05 | 1008 | 52 | 11 | CID000000813 |
| Drug | Ultracet | 1.39e-05 | 64 | 52 | 4 | CID000005523 | |
| Drug | dinotefuran | 1.45e-05 | 21 | 52 | 3 | CID000197701 | |
| Drug | meproadifen | 1.45e-05 | 21 | 52 | 3 | CID000189752 | |
| Drug | Ab-9 | 1.45e-05 | 21 | 52 | 3 | CID006540280 | |
| Drug | L-2-amino-4-methylthio-cis-but-3-enoic acid | 1.53e-05 | 3 | 52 | 2 | CID006439623 | |
| Drug | sazetidine-A | 1.53e-05 | 3 | 52 | 2 | ctd:C514816 | |
| Drug | benzylphosphate | 1.53e-05 | 3 | 52 | 2 | CID000074359 | |
| Drug | tetranitrofluorenone | 1.53e-05 | 3 | 52 | 2 | CID000069780 | |
| Drug | carbaryl | 1.57e-05 | 66 | 52 | 4 | CID000006129 | |
| Drug | suberyldicholine | 1.68e-05 | 22 | 52 | 3 | CID000123989 | |
| Drug | AR-R17779 | 1.68e-05 | 22 | 52 | 3 | CID005310971 | |
| Drug | histrionicotoxin | 1.68e-05 | 22 | 52 | 3 | CID005282247 | |
| Drug | clothianidin | 1.68e-05 | 22 | 52 | 3 | CID000213027 | |
| Drug | AC1L3BL8 | 1.93e-05 | 23 | 52 | 3 | CID000086457 | |
| Drug | alpha-conotoxin ImI | 1.93e-05 | 23 | 52 | 3 | CID000133011 | |
| Drug | CID6325740 | 1.93e-05 | 23 | 52 | 3 | CID006325740 | |
| Drug | ABT-418 | 1.93e-05 | 23 | 52 | 3 | CID000119380 | |
| Drug | alpha-conotoxin SI | 1.93e-05 | 23 | 52 | 3 | CID000163979 | |
| Drug | Skpymrfamide | 1.93e-05 | 23 | 52 | 3 | CID000132661 | |
| Drug | procyclidine | 2.20e-05 | 24 | 52 | 3 | CID000004919 | |
| Drug | AC1L2IZE | 2.20e-05 | 24 | 52 | 3 | CID000072928 | |
| Drug | intruder | 2.20e-05 | 24 | 52 | 3 | CID000213021 | |
| Drug | anabaseine | 2.20e-05 | 24 | 52 | 3 | CID000018985 | |
| Drug | arecoline | 2.22e-05 | 72 | 52 | 4 | CID000002230 | |
| Drug | anabasine | 2.49e-05 | 25 | 52 | 3 | CID000002181 | |
| Drug | varenicline | 2.49e-05 | 25 | 52 | 3 | CID000170361 | |
| Drug | PrBCM | 2.49e-05 | 25 | 52 | 3 | CID000037396 | |
| Drug | pempidine | 2.49e-05 | 25 | 52 | 3 | CID000006603 | |
| Drug | benzquinamide | 2.81e-05 | 26 | 52 | 3 | CID000002342 | |
| Drug | beta-eudesmol | 2.81e-05 | 26 | 52 | 3 | CID000091457 | |
| Drug | curarine | 2.81e-05 | 26 | 52 | 3 | CID000198004 | |
| Drug | imidazolidine | 2.81e-05 | 26 | 52 | 3 | CID000449488 | |
| Drug | beta-erythroidine | 3.06e-05 | 4 | 52 | 2 | ctd:C004873 | |
| Drug | NSC-187732 | 3.06e-05 | 4 | 52 | 2 | CID000302526 | |
| Drug | vinthionine | 3.06e-05 | 4 | 52 | 2 | CID000055145 | |
| Drug | seleno-DL-ethionine | 3.06e-05 | 4 | 52 | 2 | CID000145924 | |
| Drug | methylcarbamylcholine | 3.16e-05 | 27 | 52 | 3 | CID000004136 | |
| Drug | nornicotine | 3.16e-05 | 27 | 52 | 3 | CID000000412 | |
| Drug | oxotremorine-M | 3.53e-05 | 81 | 52 | 4 | CID000004629 | |
| Drug | echothiophate | 3.54e-05 | 28 | 52 | 3 | CID000010547 | |
| Drug | pentolinium | 3.54e-05 | 28 | 52 | 3 | CID000005849 | |
| Drug | Ino-Hcy | 3.89e-05 | 83 | 52 | 4 | CID000193585 | |
| Drug | bifemelane | 3.94e-05 | 29 | 52 | 3 | CID000002377 | |
| Drug | bromoacetylcholine bromide | 3.94e-05 | 29 | 52 | 3 | CID000204966 | |
| Drug | metoclopramide | 4.08e-05 | 84 | 52 | 4 | CID000004168 | |
| Drug | vecuronium | 4.37e-05 | 30 | 52 | 3 | CID000039764 | |
| Drug | methylenedioxydimethylamphetamine | 4.37e-05 | 30 | 52 | 3 | CID000551630 | |
| Drug | 6-carboxyfluorescein diacetate | 4.37e-05 | 30 | 52 | 3 | CID000151095 | |
| Drug | DL-ethionine | 4.68e-05 | 87 | 52 | 4 | CID000006205 | |
| Drug | tetrahydrodeoxycortisol | 4.83e-05 | 31 | 52 | 3 | CID000010593 | |
| Drug | AC1L1JK6 | 4.83e-05 | 31 | 52 | 3 | CID000005077 | |
| Drug | quinuclidine | 4.83e-05 | 31 | 52 | 3 | CID000007527 | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 4.30e-09 | 3 | 49 | 3 | OBA_2042107 | |
| Disease | cerebral palsy (implicated_via_orthology) | 5.12e-07 | 10 | 49 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 1.93e-06 | 15 | 49 | 3 | EFO_0801746 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 2.37e-06 | 16 | 49 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | gastrinoma (is_marker_for) | 8.10e-06 | 3 | 49 | 2 | DOID:5577 (is_marker_for) | |
| Disease | Autosomal dominant nocturnal frontal lobe epilepsy | 1.62e-05 | 4 | 49 | 2 | cv:C3696898 | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 5.64e-05 | 7 | 49 | 2 | C3696898 | |
| Disease | HOMA-B | 1.06e-04 | 55 | 49 | 3 | EFO_0004469 | |
| Disease | fasting blood glucose measurement | 1.13e-04 | 287 | 49 | 5 | EFO_0004465 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 2.80e-04 | 15 | 49 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | BMI-adjusted fasting blood glucose measurement | 6.68e-04 | 23 | 49 | 2 | EFO_0008036 | |
| Disease | Brain Diseases | 7.91e-04 | 25 | 49 | 2 | C0006111 | |
| Disease | Encephalopathies | 9.23e-04 | 27 | 49 | 2 | C0085584 | |
| Disease | Hyperplasia | 9.93e-04 | 28 | 49 | 2 | C0020507 | |
| Disease | coenzyme Q10 measurement | 1.64e-03 | 36 | 49 | 2 | EFO_0007836 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IISVTLEIPHHITQR | 141 | Q96P64 | |
| IVITVFVLNVHHRSP | 321 | P43681 | |
| IERVILHIQVSTLHP | 281 | Q8N5Z0 | |
| RSHPAVTHVSIIVQV | 251 | Q2NKJ3 | |
| TVVQRFHEHVHQPSV | 566 | O15254 | |
| TIFITHLLHVATTQP | 326 | A5X5Y0 | |
| RHRHCPVVVSEATIV | 391 | P11274 | |
| LSIVITVFVLNVHHR | 341 | Q15822 | |
| FSVILSVVVLNLHHR | 321 | P11230 | |
| VLFSHHRVTVLQATP | 276 | Q4L235 | |
| RLTHVQFNLIHPIII | 631 | Q9UI46 | |
| STNPVHAVDVVLRHL | 156 | Q9H9G7 | |
| HAIVQTLVHFINPET | 376 | P18075 | |
| KIVHQVRAAIHTPRF | 106 | Q8N5I2 | |
| IISVTLEIPHHITQR | 141 | Q5VW22 | |
| IAESIQVHSPVVHVQ | 2191 | Q14517 | |
| PRHLHILIGTSVVII | 241 | P43627 | |
| TAPQRALVITHFVHV | 216 | Q7LDG7 | |
| PRHLHVLIGTSVVII | 241 | P43628 | |
| VHVVHQIPAVSVTSV | 471 | Q01167 | |
| VILRSVHSVVNHTPS | 166 | Q9HCQ5 | |
| LPIRVHTIVISVQHD | 196 | P31153 | |
| ITVHVTRRPVLYFHI | 156 | O00180 | |
| VISEVLHQVTPVFRH | 706 | Q99665 | |
| PRHLHILIGTSVVII | 336 | P43629 | |
| VTVHASLVALHQPLI | 166 | Q9P2D6 | |
| VAIRNPLHYVSILTH | 126 | Q8NH63 | |
| HLHVLIGTSVVIIPF | 321 | Q8N743 | |
| QVIISHYRHVLGVPL | 36 | P11168 | |
| IPVRIHTIVISVQHN | 196 | Q00266 | |
| IQESVLEHFRTHPTV | 371 | Q8IVH4 | |
| VVHRFARHVSPLINV | 261 | Q8NGJ6 | |
| HRRSQVLVEHVVPAS | 296 | Q969F2 | |
| VFRSHCIQPSVIRHV | 26 | P54886 | |
| LVSILRTTVHHAFPV | 621 | P51797 | |
| RTTVHHAFPVVTENR | 626 | P51797 | |
| AVVIAVHSQTIQIPH | 1571 | P29400 | |
| IERINEHAPTIHVVT | 256 | Q8TDW7 | |
| AVIVLAVVLSRHQAP | 21 | P36269 | |
| IISVTLEIPHHITQR | 141 | Q5VUJ5 | |
| ISRVFIATHFPHQVI | 166 | Q9NQR9 | |
| AHVLHLRGVLTTQPV | 51 | Q9NWL6 | |
| VQHVIHYQVPRTSEI | 656 | Q9GZR7 | |
| QSNKLSHVHRIPVVV | 176 | Q9Y4X4 | |
| SHVHRIPVVVQSVPV | 181 | Q9Y4X4 | |
| PRHLHILIGTSVVII | 241 | P43626 | |
| VQHVVIGPSSLIVHF | 1066 | P08581 | |
| TEAVVITQVCHPHRI | 251 | O60522 | |
| VAFHSVIHAIRPELV | 211 | Q8NF91 | |
| FEALQVHREVIPTHT | 281 | Q96BN2 | |
| HHVVRVPHTQAVVLN | 376 | Q9UBF8 | |
| ITHHAVILFVLVPVA | 121 | Q8TBR7 | |
| ELQTHTFPITIIHGV | 1641 | Q86YA3 | |
| REVTLHLNPISSVHI | 81 | Q03167 | |
| SVRNIFHLFHDVVPT | 511 | O43264 |